NCT03071757
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Phase 1
Drug Category: Immunotherapy, Therapeutic Antibody
Key Eligibility Criteria:
Gender: All
Age: 18 Years to 99 Years (Adult, Senior)
Location of Metastases:
Additional Notes:
Exclusions: Has known uncontrolled metastases to the central nervous system (CNS).
https://ClinicalTrials.gov/show/NCT03071757